Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2-(6-(5-chloro-2-((oxan-4-yl)amino)pyrimidin-4-yl)-1-oxo-2,3-dihydro-1h-isoindol-2-yl)-n-(1-(3-fluoro-5-methoxyphenyl)-2-hydroxyethyl)propanamide
1. Astx-029
2. Compound 15 [pmid: 34387469]
3. Compound 15 (pmid: 34387469)
4. 2h-isoindole-2-acetamide, 6-(5-chloro-2-((tetrahydro-2h-pyran-4-yl)amino)-4-pyrimidinyl)-n-((1s)-1-(3-fluoro-5-methoxyphenyl)-2-hydroxyethyl)-1,3-dihydro-alpha-methyl-1-oxo-, (alphar)-
5. 2h-isoindole-2-acetamide, 6-[5-chloro-2-[(tetrahydro-2h-pyran-4-yl)amino]-4-pyrimidinyl]-n-[(1s)-1-(3-fluoro-5-methoxyphenyl)-2-hydroxyethyl]-1,3-dihydro-alpha-methyl-1-oxo-, (alphar)-
6. Erk Inhibitor Astx029
7. Erk 1/2 Inhibitor Astx029
8. Extracellular Signal-regulated Kinase Inhibitor Astx029
9. Extracellular Signal-regulated Kinase 1/2 Inhibitor Astx029
10. 2-(6-(5-chloro-2-((oxan-4-yl)amino)pyrimidin-4-yl)-1-oxo-2,3-dihydro-1h-isoindol-2-yl)-n-(1-(3-fluoro-5-methoxyphenyl)-2-hydroxyethyl)propanamide
11. 2h-isoindole-2-acetamide, 6-(5-chloro-2-((tetrahydro-2h-pyran-4-yl)amino)-4-pyrimidinyl)-n-((1s)-1-(3-fluoro-5-methoxyphenyl)-2-hydroxyethyl)-1,3-dihydro-.alpha.-methyl-1-oxo-, (.alpha.r)-
12. 2095719-92-7
13. Erk1/2 Inhibitor 2
14. (alphar)-6-[5-chloro-2-[(tetrahydro-2h-pyran-4-yl)amino]-4-pyrimidinyl]-n-[(1s)-1-(3-fluoro-5-methoxyphenyl)-2-hydroxyethyl]-1,3-dihydro-alpha-methyl-1-oxo-2h-isoindole-2-acetamide
15. 14fdk6isc9
16. (2r)-2-[5-[5-chloro-2-(oxan-4-ylamino)pyrimidin-4-yl]-3-oxo-1h-isoindol-2-yl]-n-[(1s)-1-(3-fluoro-5-methoxyphenyl)-2-hydroxyethyl]propanamide
17. Beroterkib
18. (r)-2-(6-(5-chloro-2-((tetrahydro-2h-pyran-4-yl)amino)pyrimidin-4-yl)-1-oxoisoindolin-2-yl)-n-((s)-1-(3-fluoro-5-methoxyphenyl)-2-hydroxyethyl)propanamide
19. (2~{r})-2-[5-[5-chloranyl-2-(oxan-4-ylamino)pyrimidin-4-yl]-3-oxidanylidene-1~{h}-isoindol-2-yl]-~{n}-[(1~{s})-1-(3-fluoranyl-5-methoxy-phenyl)-2-oxidanyl-ethyl]propanamide
20. Beroterkib [inn]
21. Beroterkib Anhydrous
22. Unii-14fdk6isc9
23. Chembl4847260
24. Schembl18765557
25. Gtpl11727
26. Bdbm418007
27. Ex-a4375
28. Nsc836440
29. Us10457669, Example 685
30. Akos040759413
31. Erk1/2 Inhibitor 2(astx-029)?
32. Nsc-836440
33. Us10457669, Example 1083
34. Ac-36904
35. At-35029
36. Ts-09810
37. Hy-126288
38. Cs-0101412
39. G17546
40. (
41. Ar)-6-[5-chloro-2-[(tetrahydro-2h-pyran-4-yl)amino]-4-pyrimidinyl]-n-[(1s)-1-(3-fluoro-5-methoxyphenyl)-2-hydroxyethyl]-1,3-dihydro-
42. A-methyl-1-oxo-2h-isoindole-2-acetamide
43. (2r)-2-(6-(5-chloro-2-[(oxan-4-yl)amino]pyrimidin-4-yl)-1-oxo-2,3-dihydro-1h-isoindol-2-yl)-n-[(1s)-1-(3-fluoro-5-methoxyphenyl)-2-hydroxyethyl]propanamide
44. (2r)-2-(6-{5-chloro-2-[(oxan-4-yl)amino]pyrimidin-4-yl}-1,3-dihydro-2h-1-oxoisoindol-2-yl)-n-[(1s)-1-(3-fluoro-5-methoxyphenyl)-2-hydroxyethyl]propanamide
45. (2r)-2-{6-[5-chloro-2-(oxan-4-ylamino)pyrimidin-4-yl]-1-oxo-3h-isoindol-2-yl}-n-[(1s)-1-(3-fluoro-5-methoxyphenyl)-2-hydroxyethyl]propanamide
46. (r)-2-(6-{5-chloro-2-[(tetrahydro-2h-pyran-4-yl)amino]pyrimidin-4-yl}-1-oxoisoindolin-2-yl)-n-[(s)-1-(3-fluoro-5-methoxyphenyl)-2-hydroxyethyl]propenamide
47. Ryw
Molecular Weight | 584.0 g/mol |
---|---|
Molecular Formula | C29H31ClFN5O5 |
XLogP3 | 2.9 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 9 |
Exact Mass | Da |
Monoisotopic Mass | Da |
Topological Polar Surface Area | 126 |
Heavy Atom Count | 41 |
Formal Charge | 0 |
Complexity | 900 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
12
PharmaCompass offers a list of Beroterkib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Beroterkib manufacturer or Beroterkib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Beroterkib manufacturer or Beroterkib supplier.
PharmaCompass also assists you with knowing the Beroterkib API Price utilized in the formulation of products. Beroterkib API Price is not always fixed or binding as the Beroterkib Price is obtained through a variety of data sources. The Beroterkib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Beroterkib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Beroterkib, including repackagers and relabelers. The FDA regulates Beroterkib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Beroterkib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Beroterkib supplier is an individual or a company that provides Beroterkib active pharmaceutical ingredient (API) or Beroterkib finished formulations upon request. The Beroterkib suppliers may include Beroterkib API manufacturers, exporters, distributors and traders.
Beroterkib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Beroterkib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Beroterkib GMP manufacturer or Beroterkib GMP API supplier for your needs.
A Beroterkib CoA (Certificate of Analysis) is a formal document that attests to Beroterkib's compliance with Beroterkib specifications and serves as a tool for batch-level quality control.
Beroterkib CoA mostly includes findings from lab analyses of a specific batch. For each Beroterkib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Beroterkib may be tested according to a variety of international standards, such as European Pharmacopoeia (Beroterkib EP), Beroterkib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Beroterkib USP).